Articles tagged "Post-transplant diabetes"

2022 American Transplant Congress
Intermediate Term Outcomes of SGLT2 Inhibitors Amongst Diabetic Kidney Transplant Recipients
C. Song¹, A. Brown², R. Winstead¹, S. Sterling¹, I. Yakubu², J. Christensen², G. Gupta²
¹Pharmacy, VCUHS, Richmond, VA, ²VCUHS, Richmond, VA
*Purpose: The use of Sodium Glucose Linked Transporter Inhibitors (SGLT-2i) among non-transplant diabetic patients with chronic kidney disease (CKD) has demonstrated reduced cardiovascular mortality, delayed…
2021 American Transplant Congress
Are Pre-Transplant Diabetics on ACE Inhibitors at Risk for More Renal Dysfunction After Heart Transplantation?
M. Kittleson, J. Patel, D. Chang, N. Patel, S. Kim, T. Singer-Englar, R. Skorka, A. Hage, L. Czer, F. Esmailian, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Diabetic patients undergoing heart transplantation may be at greater risk of developing kidney dysfunction after heart transplantation due to calcineurin inhibitor (CNI) nephrotoxicity. It…
2021 American Transplant Congress
Renal Tubular-cell-specific Urinary Extracellular Vesicles: A Novel Biomarker for Diabetic Nephropathy After Kidney Transplantation
N. Eguchi¹, H. Lau¹, F. Zaldivar², U. G. Reddy³, E. Tantisattamo³, A. Ferrey³, D. Dafoe¹, H. Ichii¹
¹Surgery, University of California Irvine, Orange, CA, ²Pediatric Execise and Genomics Research Center, University of California Irvine, Irvine, CA, ³Medicine, University of California Irvine, Orange, CA
*Purpose: Diabetes(DM) is a leading cause of ESRD among renal transplant recipients(RTRs). However, the kinetics of diabetic nephropathy recurrence after renal transplantation(RT) remains unclear. Currently,…
2021 American Transplant Congress
Impact of Pre- and Post-transplant Outcomes on Patient-reported Outcomes in a Prospective Multicenter Trial in Kidney Transplantation
J. M. Rohan¹, J. P. Leone², E. Woodle³, D. Kaufman⁴, A. R. Shields³, A. Wiseman⁵, A. J. Matas⁶, P. West-Thielke⁷, E. King³, R. R. Alloway³
¹Children's Hospital Richmond VCU, Richmond, VA, ²Tampa General, Tampa, FL, ³U Cincinnati, Cincinnati, OH, ⁴U Wisconsin, Madison, WI, ⁵Centura Transplant, Denver, CO, ⁶U Minnesota, Minneapolis, MN, ⁷UIC, Chicago, IL
*Purpose: BEST Trial (Belatacept-based Early Steroid-withdrawal Trial) compared belatacept (BELA)-based early steroid withdrawal (ESW) regimens with a tacrolimus (TAC)-based ESW regimen across 2years. CNI free/ESW…
2021 American Transplant Congress
Renal Transplant Recipients with Low Skeletal Muscle Attenuation Have a Greater Risk of Developing New-onset Diabetes After Transplantation
A. Han, H. Kim, C. Chung, H. Ko, K. Choi, S. Min, S. Min, J. Ha
Department of Surgery, Seoul National University College of Medicine, Seoul, Korea, Republic of
*Purpose: Decreased muscle radiation attenuation on computed tomography (CT) is indicative of fat infiltration within the muscle. Such ectopic fat accumulation has recently been recognized…
2021 American Transplant Congress
Effect of Insulin versus Oral Agents on Early Glycemic Control Following Kidney Transplant
A. Petrosan, A. Santeusanio, R. Khaim, V. Delaney
Mount Sinai Hospital, New York, NY
*Purpose: Insulin therapy is commonly prescribed to treat hyperglycemia early post-kidney transplant (KTx) due to its widespread availability and ease of titration. Alternatively, there is…
2021 American Transplant Congress
Immunosuppression Regimen and Risk of Posttransplant Diabetes Among Older Kidney Transplant Recipients
K. Lentine¹, J. Ahn², M. McAdams Demarco², H. Xiao¹, S. Bunnapradist³, D. Segev², D. Axelrod¹, S. Bae², V. Dharnidharka⁴, Y. Caliskan¹, S. Chang⁴, G. Hess⁵, J. Snyder⁶, M. Schnitzler¹
¹Saint Louis Univ, Saint Louis, MO, ²Johns Hopkins, Baltimore, MD, ³Univ of California, Los Angeles, Los Angeles, CA, ⁴Washington Univ, Saint Louis, MO, ⁵Drexel Univ, Philadelphia, PA, ⁶SRTR, Minneapolis, MN
*Purpose: Posttransplant diabetes mellitus (PTDM) is a common complication after kidney transplantation (KTx), which may be exacerbated by immunosuppressive therapy (ISx). Older adults tend to…
2021 American Transplant Congress
Endocrine Cell Identity and HOMA-B In Patients with Chronic Pancreatitis Undergoing Islet Auto-transplantation
C. A. Beamish¹, O. Gaber², O. M. Sabek²
¹Surgery, Houston Mehodist Hospital, Houston, TX, ²Surgery, Houston Mehodist, Houston, TX
*Purpose: Islet identity loss is an emergent factor in dysglycemia in diabetes, islet transplantation, and chronic pancreatitis (CP). Pancreatectomy and islet auto-transplantation (PIAT) for CP…
2021 American Transplant Congress
Characterization of SGLT2 Inhibitor Use After Abdominal Transplant
F. Hailemariam¹, S. Yeager², J. Schulte³, P. Singh¹, A. Yadav¹
¹Transplant Nephrology, Thomas Jefferson University Hospital, Philadelphia, PA, ²Abdominal Transplant Pharmacist, Thomas Jefferson University Hospital, Philadelphia, PA, ³Abdominal Transplant, Clinical Pharmacist, Thomas Jefferson University Hospital, Philadelphia, PA
*Purpose: Post solid organ transplantation, diabetic kidney disease (DKD) can progress due to recurrent pre-transplantation diabetes or the development of post-transplantation diabetes mellitus (PTDM). This…
2020 American Transplant Congress
Survival with Post-Transplant Diabetes Mellitus is Worse after Heart Transplantation
K. Y. Feng¹, E. Henricksen², Y. Moayedi³, R. Lee², J. Han¹, S. Purewal¹, A. Puing¹, M. Basina¹, J. J. Teuteberg¹, K. K. Khush¹
¹Medicine, Stanford University, Palo Alto, CA, ²Pharmacy, Stanford University, Palo Alto, CA, ³Cardiology, University Health Network, Toronto, ON, Canada
*Purpose: An increasing number of patients undergoing heart transplantation (HTx) have diabetes mellitus (DM). However, there is limited data on clinical outcomes after HTx in…